Advancements in Small Cell Lung Cancer Clinical Trials
Small cell lung cancer (SCLC) is a highly aggressive form of lung cancer that accounts for approximately 10-15% of all lung cancer cases. Characterized by its rapid growth and early metastasis, SCLC is often diagnosed at an advanced stage, which significantly complicates treatment options and prognosis. The cancer originates in the neuroendocrine cells of the […]
Advancements in Small Cell Lung Cancer Clinical Trials Read More »










